Literature DB >> 24234043

Cystatin B and SOD1: protein–protein interaction and possible relation to neurodegeneration.

Lisa Ulbrich, Mauro Cozzolino, Elettra Sara Marini, Ilaria Amori, Antonella De Jaco, Maria Teresa Carrì, Gabriella Augusti-Tocco.   

Abstract

Cystatin B (CSTB), an inhibitor of the cysteine proteases, belongs to the cathepsin family and it is known to interact with a number of proteins involved in cytoskeletal organization. CSTB has an intrinsic tendency to form aggregates depending on the redox environment. The gene encoding for CSTB is frequently mutated in association with the rare neurodegenerative condition progressive myoclonus epilepsy. Increased levels of CSTB have been observed in the spinal cord of transgenic mice modeling SOD1-linked familial amyotrophic lateral sclerosis, a fatal neurodegenerative disease affecting motoneurons. In the present study, we have investigated the relationship occurring between the expression of SOD1 and CSTB either wild-type or double-cysteine substitution mutant (Cys 3 and Cys 64). Whether or not there is a physical interaction between the two proteins was also investigated in overexpression experiments using a human neuroblastoma cell line and mouse-immortalized motoneurons. Here we report evidences for a reciprocal influence of CSTB and SOD1 at the gene expression level and for a direct interaction of the two proteins.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24234043     DOI: 10.1007/s10571-013-0004-y

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  32 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients.

Authors:  N Shibata; R Nagai; K Uchida; S Horiuchi; S Yamada; A Hirano; M Kawaguchi; T Yamamoto; S Sasaki; M Kobayashi
Journal:  Brain Res       Date:  2001-10-26       Impact factor: 3.252

Review 3.  The cystatins: protein inhibitors of cysteine proteinases.

Authors:  V Turk; W Bode
Journal:  FEBS Lett       Date:  1991-07-22       Impact factor: 4.124

4.  N-acetylcysteine and Unverricht-Lundborg disease: variable response and possible side effects.

Authors:  M J J Edwards; I P Hargreaves; S J R Heales; S J Jones; V Ramachandran; K P Bhatia; S Sisodiya
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

5.  Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy.

Authors:  Riitta Rinne; Pekka Saukko; Mikko Järvinen; Anna-Elina Lehesjoki
Journal:  Ann Med       Date:  2002       Impact factor: 4.709

6.  Characterization of the cystatin B gene promoter harboring the dodecamer repeat expanded in progressive myoclonus epilepsy, EPM1.

Authors:  K Alakurtti; K Virtaneva; T Joensuu; J J Palvimo; A E Lehesjoki
Journal:  Gene       Date:  2000-01-25       Impact factor: 3.688

7.  A PCR amplification method reveals instability of the dodecamer repeat in progressive myoclonus epilepsy (EPM1) and no correlation between the size of the repeat and age at onset.

Authors:  M D Lalioti; H S Scott; P Genton; D Grid; R Ouazzani; A M'Rabet; S Ibrahim; R Gouider; C Dravet; T Chkili; A Bottani; C Buresi; A Malafosse; S E Antonarakis
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

8.  Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1)

Authors:  L A Pennacchio; A E Lehesjoki; N E Stone; V L Willour; K Virtaneva; J Miao; E D'Amato; L Ramirez; M Faham; M Koskiniemi; J A Warrington; R Norio; A de la Chapelle; D R Cox; R M Myers
Journal:  Science       Date:  1996-03-22       Impact factor: 47.728

9.  Nuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1).

Authors:  M Riccio; R Di Giaimo; S Pianetti; P P Palmieri; M Melli; S Santi
Journal:  Exp Cell Res       Date:  2001-01-15       Impact factor: 3.905

10.  The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction.

Authors:  M T Stubbs; B Laber; W Bode; R Huber; R Jerala; B Lenarcic; V Turk
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

View more
  3 in total

1.  Human stefin B role in cell's response to misfolded proteins and autophagy.

Authors:  Mira Polajnar; Tina Zavašnik-Bergant; Katja Škerget; Matej Vizovišek; Robert Vidmar; Marko Fonović; Nataša Kopitar-Jerala; Uroš Petrovič; Susanna Navarro; Salvador Ventura; Eva Žerovnik
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

2.  The amyloid interactome: Exploring protein aggregation.

Authors:  Konstantina V Biza; Katerina C Nastou; Paraskevi L Tsiolaki; Chara V Mastrokalou; Stavros J Hamodrakas; Vassiliki A Iconomidou
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

3.  A molecular view of the normal human thyroid structure and function reconstructed from its reference transcriptome map.

Authors:  Lorenza Vitale; Allison Piovesan; Francesca Antonaros; Pierluigi Strippoli; Maria Chiara Pelleri; Maria Caracausi
Journal:  BMC Genomics       Date:  2017-09-18       Impact factor: 3.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.